Rafferty Domnick Cunningham & Yaffa Welcomes Katherine A. Kiziah as Partner
Kiziah's legal career has been marked by an unwavering commitment to justice and an ability to navigate challenging cases involving product liability, catastrophic injury, and consumer protection. Her most recent achievement was an appointment by the U.S. District Judge
Her victories include a multi-million-dollar settlement on behalf of consumers harmed by contaminated compounded medications, as well as numerous other successful outcomes for individuals harmed by dangerous products and deceptive practices.
"Katherine exemplifies the core values of our firm — excellence, integrity, and a relentless dedication to our clients," said
Before joining RDCY, Kiziah served as South Florida Bureau Chief for the Florida Attorney General's Office, where she led complex civil prosecutions that dismantled large-scale fraud schemes, earning her the Attorney of the Year Award and helping the
A recognized leader in the legal community, Kiziah serves as Secretary of the Palm Beach County Justice Association, Co-Chair of the AAJ Surgical Stapler Litigation Group, and is a Past President of the Palm Beach County Chapter of the Florida Association for Women Lawyers. Her work has been honored with numerous accolades, including Best Lawyers in America (2025) and Florida Trend Legal Elite.
About
For media inquiries, please contact:
Chief Strategy Officer (CSO)
Phone: (561) 516-5168
Email: [email protected]
Agency contact:
AMPLIFY
Phone: (561) 717-6499
Email: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/rafferty-domnick-cunningham--yaffa-welcomes-katherine-a-kiziah-as-partner-302433624.html
SOURCE
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- STEMREGEN® Named to Inc. 5000 for Third Consecutive Year
- FDIC Appoints Sunwest Bank as Nano Banc's Acquiring Institution
- Kodiak Sciences to Present Topline Results on September 28, 2026 from DAYBREAK Pivotal Phase 3 Study of Zenkuda and KSI-501 in Patients with Wet Age-Related Macular Degeneration
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share